Epstein-Barr Virus and Associated Diseases pp 644-659 | Cite as
Management of Nasopharyngeal Carcinoma
Chapter
Abstract
Nasopharyngeal carcinoma is rare in most countries (incidence rate of less than 1 per 100,000) but is a major health problem in some regions (incidence rate as high as 5.8 per 100,000 with a mortality rate of 2.6 per 100,000 reported in 1981 from Taiwan). A search for etiologic factors and development of specific methods of eradication of this cancer remain the focus of investigation by many workers in the field and is the subject of this Symposium. Equally necessary, however, are continued efforts to identify early cases through serologic and cytologic screening, and the development of more effective therapeutic modalities for all stages of illness. The current survival rate of 30–60% reported from various regions of the world is a phase of clinical development which warrants further improvement.
Keywords
Nasal Cavity Nasopharyngeal Carcinoma Radiation Therapy Oncology Group Cranial Nerve Palsy Nasopharyngeal Cancer
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
References
- Connors, J.M., Andiman, W.A., Merigan, T.C., Treatment of nasopharyngeal carcinoma with interferon:Epstein-Barr virus serology and clinical results of a pilot study. Proc. Amer. Soc. Clin. Oncol, abstract C-771 (1982).Google Scholar
- Cooper, J.S., Del Rowe, J., and Newell, J., Regional stage IV carcinoma of the nasopharynx treated by aggressive radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 9: 1737–1745 (1983).PubMedGoogle Scholar
- Dharmalingam, S.K., Singh, P., Tan, M.K., Singaram, S.P., and Prasa, U., Cyclophosphamide, vincristine, methotrexate, and adriamycin in untreated nasopharyngeal carcinoma; a report from Malaysian trial on chemotherapy in nasopharyngeal carcinoma. In: U. Prasad, D.V. Ablashi, P.H. Levine, and G.R Pearson (ed.), Nasopharyngeal Carcinoma, Current Concepts, p. 402 (1983).Google Scholar
- Fletcher, G.H., and Million, R.R., Malignant tumors of the nasopharynx. Am. J. of Roentgenol Radium Ther. Nucl. Med. 93: 44–55 (1965).Google Scholar
- Fu, K.K., Newman, H., and Phillips, T.L., Treatment of locally recurrent carcinoma of the nasopharynx. Radiology 117: 425–431 (1975).PubMedGoogle Scholar
- Galligioni, E., Carbone, A., Tirelli, U., Veronesi, A., Trovo, M.G., Donatella, M.M., Crivellari, D., Roncadin, M., Frustaci, S., Tumdo, S., and Grigoletto, E., Combined chemo therapy with doxorubicin, bleomycin, vinblastine, dacarbazine and radiotherapy for advanced lymphoepithelioma. Cancer Treatment Reports 66: 1207–1209 (1982).PubMedGoogle Scholar
- Goepfert, H., Moran, M.E., and Lindberg, R.D., Chemotherapy of advanced nasopharyngeal carcinoma. Proc. Amer. Clin. Oncol. 22: 401 (abstract) (1981).Google Scholar
- Ho, J.H.C., An epidemiologic and clinical study of naso-pharyngeal cancer. Int. J. Radiat. Oncol. Biol. Phys. 4: 183–198 (1978).CrossRefGoogle Scholar
- Hoppe, R.T., Gothenet, D.R., and Bagshaw, M.A., Carcinoma of the nasopharynx; eighteen years experience with mega- voltage radiation therapy. Cancer 37: 2605–2612 (1976).PubMedCrossRefGoogle Scholar
- Huang, A.T., Cole, R.B., and Jelovsek, S.B., Adjuvant treatment of nasopharyngeal carcinoma. In: Nasopharyngeal Carcinoma, Current Concepts. University of Malaya Press, Kuala Lumpur, p. 397–401 (1983).Google Scholar
- Huang, S.C., Nasopharyngeal cancer; a review of 1,605 pa-tients treated radically with cobalt 60. Int. J. Radiat. Oncol. Biol. Phys. 6: 401–407 (1980).PubMedCrossRefGoogle Scholar
- Hsu, M.M., and Tu, S.M., Nasopharyngeal carcinoma in Taiwan. Cancer 52: 361–368 (1983).Google Scholar
- Jenkin, R.D.T., Anderson, J.R., Jereb, B., Thompson, J.C., Pyesmany, A., Wara, W.M., and Hammond. D., Nasopharyngeal carcinoma - a retrospective review of patients less than 30 years of age. Cancer 47: 360–366 (1981).PubMedCrossRefGoogle Scholar
- Lederman, M., Cancer of the nasopharynx. Charles C. Thomas (1961).Google Scholar
- Marcial, V.A., Hanley, J.A., Chang, C., Davis, L.W., and Moscol, J.A., Split-course radiation therapy of carcinoma of the nasopharynx; results of a national collaborative clinical trial of the radiation therapy oncology group. Int. J. Radiat. Oncol. Biol. Phys. 6: 409–414 (1980).PubMedCrossRefGoogle Scholar
- Marks, J.E., Bedwineck, J.M., Lee, F., Purdy, J.A:, and Perez, C.A., Dose-response analysis for nasopharyngeal carcinoma. Cancer 50: 1042–1050 (1982).PubMedCrossRefGoogle Scholar
- McNeese, M.D., and Fletcher, G.H., Retreatment of recurrent nasopharyngeal carcinoma. Radiology 138: 191–193 (1981).PubMedGoogle Scholar
- Meyer, J.E., and Huang, C.C., Carcinoma of the nasopharynx. Radiology 100: 385–388 (1971).PubMedGoogle Scholar
- Million, R.R., and Cassisi, N.J., Management of head and neck cancer. J.B. Lippincott (1984).Google Scholar
- Moench, H.C., Phillips, T.L., Carcinoma of the nasopharynx: review of 146 patients with emphasis on radiation dose and time factors. Am. J. Surg. 124: 515–518 (1972).PubMedCrossRefGoogle Scholar
- Treuner, J., Niethammer, D., Dannecker, G., Jobke, A., Aldenhoff, P., Kremens, B., Nessler, G., and Bommer, H., Treatment of nasopharyngeal carcinoma in children with fibroblast interferon. In: E. Grundmann, G.R.F. Krueger, and D.V. Ablashi (ed.), Nasopharyngeal Carcinoma: Cancer Campaign, Vol 5, pp 309–316, Gustav Fischer Verlag, Stuttgart, New York (1981).Google Scholar
- Wang, C.C., Radiation therapy for head and neck neoplasms. John Wright (1983).Google Scholar
- Yan, J.H., Hu, Y.H., and Gu, X.Z., Radiation therapy of re-current nasopharyngeal carcinoma; report on 219 patients. Acta Radiol. (Oncol.) 22: 23–28 (1983).CrossRefGoogle Scholar
Copyright information
© Martinus Nijhoff Publishing, Boston 1985